Literature DB >> 17562091

Electrophysiologic findings in chloroquine maculopathy.

Regina Halfeld Furtado de Mendonça1, Otacílio Oliveira Maia, Walter Yukihiko Takahashi.   

Abstract

PURPOSE: To describe an interesting case with a typical chloroquine bull's eye maculopathy with important results of the electrophysiological tests and verify if any reduction of focal responses, detected in multifocal electroretinogram (mfERG), are congruent with any possible defects detected in the visual field. CASE REPORT: A 59-year-old man took a daily dosage of 250 mg chloroquine for his rheumatoid arthritis (up to a total dose of 540 g). He had the typical chloroquine-induced bull's-eye maculopathy. The electro-oculogram was normal. The mfERG, demonstrated reduced focal responses in the areas corresponding to the scotoma detected in the visual field.
CONCLUSIONS: Considering the normality of the electro-oculogram, we can easily conclude that the electro-oculogram is not sensible to detect chloroquine maculopathy and that reported reductions may occur due to the course of the rheumatoid arthritis itself. The mfERG may be an important ophthalmological screening and follow-up management to investigate patients using chloroquine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17562091     DOI: 10.1007/s10633-007-9060-2

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  13 in total

1.  THE EOG IN CHLOROQUINE AND OTHER RETINOPATHIES.

Authors:  P GOURAS; R D GUNKEL
Journal:  Arch Ophthalmol       Date:  1963-11

2.  Retinal vasculitis as a complication of rheumatoid arthritis.

Authors:  T Matsuo; T Koyama; N Morimoto; H Umezu; N Matsuo
Journal:  Ophthalmologica       Date:  1990       Impact factor: 3.250

3.  Interpretation of the electro-oculogram of patients taking chloroquine.

Authors:  C N Reijmer; J G Tijssen; G A Kok; G H van Lith
Journal:  Doc Ophthalmol       Date:  1980-04-15       Impact factor: 2.379

4.  [Statistical results of 700 electrophysiologic tests (ERG) in patients without ophthalmologic manifestations treated with synthetic antimalarials for rheumatologic or dermatologic disease].

Authors:  F Rigaudière; M Pizzato; E Albuisson; J F Le Gargasson; Y Grall
Journal:  Ophtalmologie       Date:  1990 May-Jun

5.  Geographic choroiditis and retinal vasculitis in rheumatoid arthritis.

Authors:  T Matsuo; I Masuda; N Matsuo
Journal:  Jpn J Ophthalmol       Date:  1998 Jan-Feb       Impact factor: 2.447

6.  [Chloroquine-induced bull's eye maculopathy without electrophysiologic changes].

Authors:  C Cursiefen; U Grunert; A Jünemann
Journal:  Klin Monbl Augenheilkd       Date:  1997-06       Impact factor: 0.700

7.  Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.

Authors:  Raj K Maturi; Minzhong Yu; Richard G Weleber
Journal:  Arch Ophthalmol       Date:  2004-07

8.  Assessing hydroxychloroquine toxicity by the multifocal ERG.

Authors:  Michael N Moschos; Marilita M Moschos; Michael Apostolopoulos; John A Mallias; Christos Bouros; George P Theodossiadis
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

9.  Retinal vasculitis in rheumatoid arthritis: an angiographic study.

Authors:  N Giordano; M D'Ettorre; G Biasi; A Fioravanti; L Moretti; R Marcolongo
Journal:  Clin Exp Rheumatol       Date:  1990 Mar-Apr       Impact factor: 4.473

10.  Detecting chloroquine retinopathy: electro-oculogram versus colour vision.

Authors:  A S Neubauer; K Samari-Kermani; U Schaller; U Welge-Lübetaen; G Rudolph; T Berninger
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

View more
  2 in total

1.  Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up.

Authors:  Paul Salu; André Uvijls; Pierre van den Brande; Bart P Leroy
Journal:  Doc Ophthalmol       Date:  2010-04-16       Impact factor: 2.379

2.  Multifocal electroretinography after high dose chloroquine therapy for malaria.

Authors:  Aline Correa de Carvalho; Martin Schwarz; Givago da Silva Souza; Bruno Duarte Gomes; Alexandre Antônio Marques Rosa; Ana Maria Revoredo da Silva Ventura; José Maria de Souza; Luiz Carlos de Lima Silveira; Jan Kremers
Journal:  J Ophthalmic Vis Res       Date:  2013-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.